Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION - Health Canada Drug Approval Details

Approvals/Health Canada/VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Authorized

STANDARD

VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION

VPI Pharmaceuticals Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 9e9b4514795478a8
Company: VPI Pharmaceuticals Inc
Type: Standard

Approval Details

Approval Id: 9e9b4514795478a8
Drug Approval Canada Name: VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Product Name: VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Status: Approved
Status Date: 2016-02-29
Din: 02452561
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:12.16.16
Atc Original: J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name: j 01 cr 05
Aig Number: 0225919006
Company Name: VPI Pharmaceuticals Inc
Company Address: 16667 Hymus Boulevard, Kirkland, Quebec, Canada, H9H 4R9
Company Detail Path: /organization/vpi-pharmaceuticals-inc

Company Information

Pharmaceutical Company Name: VPI Pharmaceuticals Inc
Country Name: Canada
Province Name: Quebec
City Name: kirkland,quebec,country_ca
Address: 16667 boul Hymus

Active Ingredients

PIPERACILLIN (PIPERACILLIN SODIUM)

4 G / VIAL

TAZOBACTAM (TAZOBACTAM SODIUM)

0.5 G / VIAL

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9e9b4514795478a8

Type

Standard

Back to Health Canada Approvals